CG

Chris Garabedian

CEO at Xontogeny

Boston, Massachusetts

Overview

Work Experience

X

Xontogeny

  • Chairman and CEO

    2016 - Current

PA

Perceptive Advisors

  • Portfolio Manager, Venture (PXV Fund)

    2017

C

CereVasc

  • Board Member

    2020

Landos Biopharma, Inc.

  • Chairman of the Board

    2017 - 2024

FB

Forge Biologics

  • Chairman of the Board

    2020 - 2023

TB

The Boston Consulting Group (BCG)

  • Senior Advisor to Healthcare Practice

    2016 - 2021

Quellis Biosciences

  • Chairman of the Board

    2017 - 2021

ST

Sarepta Therapeutics

  • Chief Executive Officer

    2011 - 2015

Education

Investments

Marea Therapeutics

Series B

Total Funding: $260M

CereVasc

Series A

Total Funding: $110M

Delve Bio

Series A

Total Funding: $35M

Tellus Therapeutics

Seed

Total Funding: $37M

Relevant Websites